153 related articles for article (PubMed ID: 6273339)
1. Liver cell dysplasia in association with hepatocellular carcinoma, cirrhosis and hepatitis B surface antigen in Hong Kong.
Ho JC; Wu PC; Mak TK
Int J Cancer; 1981 Nov; 28(5):571-4. PubMed ID: 6273339
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B surface antigen, hepatocellular carcinoma and cirrhosis in hong kong: a necropsy study: 1963-1976.
Gibson JB; Wu PC; Ho JC; Lauder IJ
Br J Cancer; 1980 Sep; 42(3):370-7. PubMed ID: 6252929
[TBL] [Abstract][Full Text] [Related]
3. Liver cell dysplasia in liver cirrhosis and hepatocellular carcinoma.
Szczepański W
Pol J Pathol; 1997; 48(3):147-57. PubMed ID: 9401407
[TBL] [Abstract][Full Text] [Related]
4. Liver cell dysplasia and hepatitis B surface antigen in liver cirrhosis and hepatocellular carcinoma.
Akagi G; Furuya K; Kanamura A; Chihara T; Otsuka H
Cancer; 1984 Jul; 54(2):315-8. PubMed ID: 6202391
[TBL] [Abstract][Full Text] [Related]
5. An autopsy study of hepatocellular carcinoma in Hong Kong.
Ho J; Wu PC; Kung TM
Pathology; 1981 Jul; 13(3):409-16. PubMed ID: 6272177
[TBL] [Abstract][Full Text] [Related]
6. Liver cell dysplasia and hepatitis B surface and core antigens in cirrhosis and hepatocellular carcinoma of autopsy cases.
Sakurai M
Acta Pathol Jpn; 1978 Sep; 28(5):705-19. PubMed ID: 216229
[TBL] [Abstract][Full Text] [Related]
7. Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis.
Yang HI; Tseng TC; Liu J; Lee MH; Liu CJ; Su TH; Batrla-Utermann R; Chan HL; Kao JH; Chen CJ
Clin Gastroenterol Hepatol; 2016 Mar; 14(3):461-468.e2. PubMed ID: 26598229
[TBL] [Abstract][Full Text] [Related]
8. Immunocytochemical investigation of hepatitis B virus-associated antigens in cases of liver cirrhosis and HBsAg antigenemia and their relationship to development of hepatocellular carcinoma.
Iwai M; Kashiwadani M; Okuno T; Takino T; Ibata Y
Histochem J; 1988 May; 20(5):283-9. PubMed ID: 2850288
[TBL] [Abstract][Full Text] [Related]
9. [Expression of ras oncogene p21 product and proliferating cell nuclear antigen in liver cirrhosis and the correlation with liver cell dysplasia].
Feng Z; He R; Lu Z; Ling Y
Zhonghua Gan Zang Bing Za Zhi; 2000 Dec; 8(6):343-5. PubMed ID: 11135691
[TBL] [Abstract][Full Text] [Related]
10. Impact of age and gender on risk of hepatocellular carcinoma after hepatitis B surface antigen seroclearance.
Yip TC; Chan HL; Wong VW; Tse YK; Lam KL; Wong GL
J Hepatol; 2017 Nov; 67(5):902-908. PubMed ID: 28652084
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
Vaiphei K; Pal NS; Arora SK
Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma. A study of 50 autopsy cases with detection of hepatitis B surface antigen in fixed tissues.
Perez-Barrios A; Colina-Ruizdelgado F; Gallego I; Martinez-Tello FJ
Pathol Res Pract; 1983 Mar; 176(2-4):131-44. PubMed ID: 6190153
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with non-cirrhotic and cirrhotic chronic viral hepatitis.
Libbrecht L; Craninx M; Nevens F; Desmet V; Roskams T
Histopathology; 2001 Jul; 39(1):66-73. PubMed ID: 11454046
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma arising in noncirrhotic and highly cirrhotic livers: a comparative study of histopathology and frequency of hepatitis B markers.
Okuda K; Nakashima T; Sakamoto K; Ikari T; Hidaka H; Kubo Y; Sakuma K; Motoike Y; Okuda H; Obata H
Cancer; 1982 Feb; 49(3):450-5. PubMed ID: 6277447
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus, hepatocellular carcinoma and liver cirrhosis in Kenya.
Mwangi J; Gatei DG
East Afr Med J; 1993 Apr; 70(4 Suppl):34-6. PubMed ID: 8223308
[TBL] [Abstract][Full Text] [Related]
16. Iron, ferritin, hepatitis B surface and core antigens in the livers of Chinese patients with hepatocellular carcinoma.
Zhou XD; DeTolla L; Custer RP; London WT
Cancer; 1987 Apr; 59(8):1430-7. PubMed ID: 3028601
[TBL] [Abstract][Full Text] [Related]
17. Liver cell dysplasia in normal, cirrhotic, and hepatocellular carcinoma patients.
Cohen C; Berson SD
Cancer; 1986 Apr; 57(8):1535-8. PubMed ID: 3004693
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis-B surface antigen and hepatocellular carcinoma in Taiwan. With special reference to types and localization of HBsAg in the tumor cells.
Hsu HC; Lin WS; Tsai MJ
Cancer; 1983 Nov; 52(10):1825-32. PubMed ID: 6313175
[TBL] [Abstract][Full Text] [Related]
19. The rs2296651 (S267F) variant on NTCP (SLC10A1) is inversely associated with chronic hepatitis B and progression to cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis B.
Hu HH; Liu J; Lin YL; Luo WS; Chu YJ; Chang CL; Jen CL; Lee MH; Lu SN; Wang LY; You SL; Yang HI; Chen CJ;
Gut; 2016 Sep; 65(9):1514-21. PubMed ID: 26642861
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma in Chinese males and females. Possible causes for the male predominance.
Lai CL; Gregory PB; Wu PC; Lok AS; Wong KP; Ng MM
Cancer; 1987 Sep; 60(5):1107-10. PubMed ID: 3038298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
